Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01402050 · ClinicalTrials.gov registry record · NA

Foley Catheter Versus Cervidil for Induction of Labor at Term

A NA study of Labor Induction, sponsored by Pediatrix.

Completed
Registry status
NA
Development phase
376
Enrollment target
2
Study locations

NCT01402050: Completed NA study of Labor Induction, sponsored by Pediatrix.

NCT01402050 is a NA study of Labor Induction that has completed, run by Pediatrix. The registered enrollment target is 376 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01402050, a NA study of Labor Induction, has completed, sponsored by Pediatrix.

COMPLETED
Registry status
NA
Development phase
376 participants
Enrollment target
2
Study locations

Study Summary

OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction. HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley catheter will decrease the mean time from induction to delivery by six hours compared to controlled release prostaglandin (Cervidil™).

Primary Outcome

The primary outcome variable was time (measured in hours) from first attempt at study agent placement to delivery. Time of placement of Labor Induction agent was noted as the time of Labor Induction initiation and time of delivery was noted as the end time of Labor Induction. There were no specific time points at which the outcomes were measured due to the uncertainty of the labor process. Total time duration of Labor induction was noted in hours. Key word: INDUCTION OF LABOR

Conditions Studied

Interventions

  • DRUG CERVIDIL (Dinoprostone)
  • DEVICE FOLEY BALLOON

Study Locations (2)

Arizona

  • Banner Desert Medical Center - Mesa
  • Banner Good Samaritan Medical Center - Phoenix

Trial Details

FieldValue
Enrollment Target 376 participants
Start Date 2010-06
Est. Completion 2015-02
Phase NA
Pediatrix

28 total trials

What the finished NCT01402050 record still lists

NCT01402050 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Labor Induction appearing as the primary indexed condition, and to 2 interventions - of which CERVIDIL (Dinoprostone) is the first listed.

NCT01402050 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT01402050 about?

NCT01402050 is a clinical study titled "Foley Catheter Versus Cervidil for Induction of Labor at Term". OBJECTIVE: To assess the efficacy of transcervical Foley catheter compared to controlled release prostaglandin (Cervidil™) for cervical ripening in term and near term women presenting for labor induction. HYPOTHESIS: In term and near term women presenting for labor induction, transcervical Foley ca...

What is the current status of trial NCT01402050?

This trial is currently completed. It is a NA study. The enrollment target is 376 participants. The study started on 2010-06. Estimated completion is 2015-02.

What conditions does trial NCT01402050 study?

This clinical trial studies the following conditions: Labor Induction.

What interventions are being tested in trial NCT01402050?

The interventions under investigation include: CERVIDIL (Dinoprostone) (DRUG), FOLEY BALLOON (DEVICE).

Who is sponsoring clinical trial NCT01402050?

This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01402050 being conducted?

This trial has 2 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Induction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01402050's enrollment target sits among peer trials

376 274th of 2000 higher than 1,725 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03102125 · 376 participants · Phase 4

    Allograft Dysfunction in Heart Transplant

  • NCT05055297 · 376 participants · NA

    SELUTION4BTK Trial

  • NCT05912647 · 376 participants · NA

    Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

  • NCT05963971 · 376 participants · NA

    A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01402050, the US trial registry maintained by the National Library of Medicine. NCT01402050 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.